Hims & Hers Health, Inc. (HIMS) Tops Q3 EPS by 22c; beats on guidance

Hims & Hers Health, Inc. (NYSE: HIMS) reported Q3 EPS of $0.32, $0.22 better than the analyst estimate of $0.10. Revenue for the quarter came in at $401.6 million versus the consensus estimate of $382.2 million.

GUIDANCE:

Hims & Hers Health, Inc. sees Q4 2024 revenue of $465-470 million, versus the consensus of $421.1 million.

Hims & Hers Health, Inc. sees FY2024 revenue of $1.46-1.465 billion, versus the consensus of $1.4 billion.

For earnings history and earnings-related data on Hims & Hers Health, Inc. (HIMS) click here.

You May Also Be Interested In

• RH (RH) Tops Q1 EPS by 12c
• TechCreate Group faces NYSE American delisting proceedings
• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO